Screening and Toxicity Analysis of Catechin Isomers Against FemA Protein

Divya Singhal1, S Saxena1

  • 1Department of Biotechnology, Thapar University, Patiala-147 004, India.

Insights

This study computationally evaluated FemA protein interactions with catechin and epicatechin analogues. Catechin gallate emerged as the optimal ligand, demonstrating superior binding affinity and favorable properties for FemA protein.

Area of Science:

  • Microbiology
  • Structural Biology
  • Computational Chemistry

Background:

  • Fem proteins are crucial structural components in gram-positive bacteria.
  • Three types exist: FemX (FmhB), FemA, and FemB.
  • Limited crystallographic data is available for Fem proteins, with only FemA from Staphylococcus aureus and FemX from Weissella viridescens characterized to date.

Purpose of the Study:

  • To computationally assess the binding interactions between the FemA protein and various catechin and epicatechin analogues.
  • To identify potential inhibitors or modulators of FemA protein function through molecular docking and screening.

Main Methods:

  • Utilized computational methods, including Autodock Vina and UCSF Dock, for molecular docking simulations.
  • Employed Lipinski filters and toxicity assessments via online SCFBIO and OSIRIS servers to evaluate ligand properties.
  • Screened a library of catechin and epicatechin analogues for their binding affinity to the FemA protein.

Main Results:

  • Confirmed interactions between FemA protein and catechin/epicatechin analogues through binding energy and docking scores.
  • Identified catechin gallate as the most effective ligand for FemA protein based on computational analyses.
  • Catechin gallate demonstrated superior performance compared to all other tested catechin and epicatechin isomers.

Conclusions:

  • Catechin gallate is a highly promising candidate ligand for the FemA protein.
  • Computational approaches are effective for identifying potential drug leads targeting bacterial structural proteins.
  • Further experimental validation is warranted to confirm the therapeutic potential of catechin gallate against FemA-related pathways.

Related Concept Videos